As of 06 Nov 2026 15:35 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2026/031 (09 Jul 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml (Fixapost®) preservative free eye drops, 0.2ml unit doseaffected product · inferred from phrasing | Out of stock, as stated | January 2027precision: a month · window end 31 Jan 2027, derived from “January 2027” | notice of 09 Jul 2026 |
| Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml (Vizilatan Duo®) preservative free eye dropsnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 09 Jul 2026 |
| Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops (containing preservatives)named by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 09 Jul 2026 |
| Timolol (Eysano®) 5mg/ml [0.5%] preservative free eye dropsnamed by the source as remaining available · inferred from phrasing · its own page → | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 09 Jul 2026 |
| Timolol (Eysano®) 2.5mg/ml [0.25%] preservative free eye dropsaffected product · inferred from phrasing · its own page → | Out of stock, as stated | September 2026precision: a month · window end 30 Sep 2026, derived from “September 2026” | notice of 09 Jul 2026 |
| Latanoprost (Monopost®) 50micrograms/ml preservative free eye drops, 0.2ml unit dosenamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 09 Jul 2026 |
| Timolol (Tiopex®) 1mg/g [0.1%] preservative free eye gel, 0.4g unit dosenamed by the source as remaining available · inferred from phrasing · its own page → | Stated as available | — not stated for this line | notice of 09 Jul 2026 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 1 earlier protocol on this record has expired: SSP086 (to 06 Feb 2026). Matching is by name until identifier coding lands.
Named in the source as remaining available
- Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml (Vizilatan Duo®) preservative free eye drops — named by the source as remaining available (inferred from phrasing)
- Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops (containing preservatives) — named by the source as remaining available (inferred from phrasing)
- Timolol (Eysano®) 5mg/ml [0.5%] preservative free eye drops — named by the source as remaining available (inferred from phrasing)
- Latanoprost (Monopost®) 50micrograms/ml preservative free eye drops, 0.2ml unit dose — named by the source as remaining available (inferred from phrasing)
- Timolol (Tiopex®) 1mg/g [0.1%] preservative free eye gel, 0.4g unit dose — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Latanoprost
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2023 — a recurring shortage spanning 3.4 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 09 Jul 2026 | Medicine Supply Notification: Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free | Supply notification | Tier 2 | MSN/2026/031 |
| 19 Dec 2025 | Medicine Supply Notification: Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost® ) eye drops 0.2ml unit dose preservative free | Notification update | Tier 2 | MSN/2025/069 |
| 27 Feb 2023 | Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free) | Supply notification | Tier 3 | MSN/2023/023 |
Also recorded under
Bracketed names seen in this medicine's notice titles: monopost. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)56 Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml · issued 24 Dec 2025 · valid until early February 2026, as stated · matched by name PDF ↗
- MSAN(2021)32 Latanoprost 50microgram/ml / timolol 5mg/ml (Fixapost®) 0.2ml unit dose · issued 08 Nov 2021 · valid until Mid November 2021, as stated · matched by name PDF ↗